Delivery Order 36C24821D0025-36C24823N0357

Award Date 2/1/23
Potential Completion Date 1/31/24
Potential Value $200K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Port Chester, NY 10573, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Cytopath Biopsy Lab Inc., doing business as Cblpath, to provide ThyroSequence Testing Services to the Veterans Integrated Service Network 2 (VISN 2) of the Department of Veterans Affairs (VA). The contract is a Delivery Order with a Firm Fixed Price pricing type, with a total ceiling value of $120,000.00 and a period of performance through February 12, 2028. This award is not set aside and is likely part of a larger Indefinite Delivery/Indefinite Quantity...
This is a $294,000.00 firm fixed price Blanket Purchase Agreement (BPA) Call awarded by the Veterans Integrated Service Network (VISN) 19 of the Department of Veterans Affairs (VA) to Cytopath Biopsy Lab Inc., doing business as Cblpath. The contract is for the provision of ThyroSeq molecular diagnostic testing services over the period of performance ending August 31, 2024. The contract provides for Cytopath Biopsy Lab Inc. to deliver ThyroSeq genetic testing to support the VA's thyroid cancer...
This is a firm fixed price purchase order contract awarded by the Veterans Integrated Service Network 6 (VISN 6), a civilian agency within the Department of Veterans Affairs (VA), to Cytopath Biopsy Lab Inc., doing business as Cblpath. The contract is for the provision of ThyroSeq genomic classifier tests, which are specialized molecular diagnostic tests used to evaluate thyroid cancer risk. The contract has a ceiling value of $104,000.00 and a period of performance through October 31, 2024....
This is a firm fixed price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Cytopath Biopsy Lab Inc., doing business as Cblpath, to provide ThyroSeq laboratory tests to determine thyroid nodule malignancy for surgical decision making. The $72,000.00 award is part of an Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle between the VA and Cytopath Biopsy Lab Inc. to support cancer screening and diagnosis programs within the VA healthcare network. The contract...
This is a federal contract award by the U.S. Department of Veterans Affairs (VA) to Cytopath Biopsy Lab Inc., operating under the trade name Cblpath. The $148,000 firm-fixed-price delivery order contract is for ThyroSeq genetic testing services to support cancer screening and diagnosis programs for veterans and active military personnel. The contract is not set aside for any specific business category. Cytopath Biopsy Lab Inc. is a for-profit organization specializing in anatomic pathology and...
The U.S. Department of Veterans Affairs (VA) has awarded a firm-fixed-price delivery order contract to Cytopath Biopsy Lab Inc. (doing business as Cblpath) for its ThyroSeq genetic testing services. The $168,000.00 contract will provide cancer screening and diagnostic services to the VA healthcare system through January 31, 2026. Cytopath Biopsy Lab Inc. has previously provided ThyroSeq testing to support thyroid cancer screening programs at VA medical centers and the Defense Health Agency,...
This is a firm fixed price contract awarded by the U.S. Department of Veterans Affairs (VA) to Cytopath Biopsy Lab Inc., doing business as Cblpath, for the provision of ThyroSeq Genomic Classifier Tests. ThyroSeq is a molecular diagnostic test used to evaluate the malignancy of thyroid nodules, which is an important cancer screening and diagnostic capability for the VA healthcare system. The contract, valued at $32,000.00, is a Blanket Purchase Agreement (BPA) call with a period of performance...
This is a $625,500.00 firm fixed price purchase order awarded by the Veterans Integrated Service Network 7 (VISN 7), a regional network of the U.S. Department of Veterans Affairs (VA), to Cytopath Biopsy Lab Inc. (doing business as Cblpath) for Thyroid Molecular Testing services. The contract has an ultimate completion date of April 30, 2029. The contract was awarded on a sole source basis under FAR Part 13.5, as Cytopath Biopsy Lab Inc. is the exclusive manufacturer of the required ThyroSeq...
This firm fixed price purchase order was awarded by the Department of Veterans Affairs Veterans Health Administration to Cytopath Biopsy Lab Inc., doing business as Cblpath, for the provision of ThyroSeq testing kits. The $320,000.00 contract is to deliver specialized thyroid cancer diagnostic testing services, including ThyroSeq analysis of genetic mutations to evaluate malignancy of thyroid nodules, to support screening programs at VA medical centers and associated healthcare networks...
This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cytopath Biopsy Lab Inc., doing business as Cblpath, to provide ThyroSeq genetic testing services for the VA's Veterans Integrated Service Network (VISN) 22. The $366,000 contract will support thyroid cancer screening and diagnosis programs at VA healthcare facilities in California, New Mexico, Arizona, and other regional locations. The original solicitation was a...
  • 36C24821D0025
    Indefinite Delivery Contract
  • 36C24821D0025-36C24823N0357
    Delivery Order

This is a firm fixed price delivery order contract awarded by the Veterans Integrated Service Network 8 (VISN 8), a regional healthcare network within the U.S. Department of Veterans Affairs (VA), to Cytopath Biopsy Lab Inc., doing business as Cblpath. The $200,000.00 contract is for the provision of ThyroSeq genetic testing services to support cancer screening and diagnosis for veterans. ThyroSeq is a molecular diagnostic test that evaluates genetic mutations to assess the malignancy of thyroid nodules.

This award is part of a larger portfolio of federal contracts and blanket purchase agreements held by Cytopath Biopsy Lab Inc. to provide ThyroSeq testing services to VA healthcare facilities and the Defense Health Agency. The contract does not utilize a small business set-aside. The contract has an ultimate completion date of January 31, 2024.

Generated 7/3/24, 9:51 AM